Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting
Open Access
- 1 January 2014
- journal article
- research article
- Published by Elsevier in NeuroImage: Clinical
- Vol. 6, 445-454
Abstract
No abstract availableKeywords
Funding Information
- European Union's Seventh Framework Programme (HEALTH-F2-2011-278850)
- Framework Programme for Research and Technological Development “DECIDE” (RI-261593)
This publication has 51 references indexed in Scilit:
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseNew England Journal of Medicine, 2012
- Summary Metrics to Assess Alzheimer Disease–Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head ComparisonJournal of Nuclear Medicine, 2012
- Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent LiteratureJournal of Nuclear Medicine, 2011
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaBrain, 2011
- Classification of primary progressive aphasia and its variantsNeurology, 2011
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeThe Lancet Neurology, 2010
- Mild Cognitive ImpairmentArchives of Neurology, 2009
- SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy agingNeuroImage, 2009
- Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's diseaseBrain, 2007
- Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PETMolecular Genetics and Metabolism, 2003